文献速递母胎医学产科

孕早期母体原发感染且孕中期胎儿脑影像正常的先天性巨细胞病毒感染婴儿随访

Follow-Up of Infants With Congenital Cytomegalovirus Following Maternal Primary Infection in the First Trimester and Normal Fetal Brain Imaging at Midgestation.
PubMed 文献 · Prenat Diagn · 2024-12-18

回顾性单中心队列纳入2014至2021年孕早期母体原发感染、孕22周前胎儿脑影像正常的经证实先天性巨细胞病毒感染病例,共42例新生儿。出生时无症状29/42(69.1%),有症状13/42(30.9%,95%CI 17.6%-47.1%);中位随访35个月时8例(19%,95%CI 8.6%-34.1%)存在听力损失,均无严重脑异常。

要点

  • 孕中期形态扫描脑超声正常不能排除出生后神经影像异常或出生后治疗需求。
  • 出生时有症状13/42(30.9%),无症状29/42(69.1%)。
  • 中位随访35个月,听力损失8/42(19%),无严重脑异常。

核心结论

  • 对于孕早期母体原发感染未治疗、孕中期形态扫描脑超声无异常的先天性巨细胞病毒感染婴儿,不能排除出生后神经影像异常或出生后治疗需求,但本队列出生后未检出严重脑异常,唯一观察到的后遗症为感音神经性听力损失。

研究设计与样本

  • 回顾性单中心队列研究,纳入2014年至2021年孕早期母体原发感染后经证实先天性巨细胞病毒感染、且孕22周前胎儿脑影像正常的全部病例;随访不足12个月的病例被排除。
  • 所有妊娠按本方案随访:感染发生至少8周后提供羊膜腔穿刺、系列超声扫描和孕晚期胎儿MRI;孕期无女性接受巨细胞病毒超免疫球蛋白或伐昔洛韦治疗。
  • 共42例新生儿经新生儿尿液样本PCR检测巨细胞病毒基因组确诊先天性巨细胞病毒感染。

主要发现

  • 孕中期超声(孕20-22周)3/42胎儿存在脑外感染征象;孕晚期(孕28-32周)无胎儿显示脑超声异常,但4例出现巨细胞病毒感染脑外征象。
  • 42例新生儿中29例出生时分类为无症状(29/42,69.1%),13例有症状(13/42,30.9%,95%CI 17.6%-47.1%)。
  • 8例新生儿颅脑超声/MRI异常(8/42,19%),1例出生后脑影像异常伴听力损失,4例初次评估有感应神经性听力损失(SNHL);均接受口服缬更昔洛韦治疗。
  • 4例出生时听力正常的新生儿出现迟发性SNHL;1例听力损失治疗后改善并恢复正常听力。
  • 中位随访35个月时,8例婴儿有听力损失(8/42,19%,95%CI 8.6%-34.1%),无一例出现严重脑异常。

临床怎么用

  • 作者结论指出,孕中期形态扫描脑超声无异常不能排除出生后神经影像异常或出生后治疗需求;本队列出生后未检出严重脑异常,唯一观察到的后遗症为感音神经性听力损失。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine outcomes at birth and postnatal sequelae of congenital cytomegalovirus (cCMV) infection following maternal primary infection in the first trimester with normal fetal brain imaging at midgestation. METHODS: A retrospective, single-center cohort study was conducted, including all cases of proven cCMV infection following maternal primary infection in the first trimester from 2014 until 2021 and normal fetal brain imaging before 22 weeks of gestation. All pregnancies were followed according to our protocol, which offers amniocentesis at least 8 weeks after the onset of infection, serial ultrasound scans, and a fetal MRI in the third trimester. No women received treatment with CMV hyperimmune globulin or Valacyclovir during pregnancy. Follow-up of newborns was obtained, and newborns were classified as symptomatic or asymptomatic at birth. Postnatal sequelae were evaluated, and cases with a follow-up period of less than 12 months were excluded. RESULTS: We found 42 newborns with cCMV, confirmed at birth by PCR for the CMV genome in neonatal urine samples, and normal fetal brain imaging up to 22 weeks of gestation. Extracerebral signs of infection were present in 3/42 fetuses at the second trimester ultrasound (20-22 weeks of gestation). In the third trimester (28-32 weeks of gestation), none showed abnormal brain sonographic findings, but four exhibited extracerebral signs of CMV infection. Among 42 newborns, 29 were classified as asymptomatic (29/42, 69.1%) and 13 as symptomatic at birth (13/42, 30.9%, 95%CI 17.6%-47.1%). Eight newborns had abnormal cranial ultrasound/MRI (8/42, 19%), one presented abnormal postnatal brain imaging associated with hearing loss and four had sensorineural hearing loss (SNHL) at initial assessment. All were treated with oral Valganciclovir. Four newborns with normal hearing at birth had delayed onset SNHL. One case of hearing loss improved after treatment and returned to normal hearing. At a median follow-up of 35 months, 8 infants had hearing loss (8/42, 19%, 95%CI 8.6%-34.1%) and none presented with severe brain abnormalities. CONCLUSION: For infants with congenital CMV following untreated first trimester maternal primary infection, the absence of abnormal prenatal brain ultrasound findings at the mid-trimester morphology scan does not rule out the possibility of postnatal neuroimaging anomalies or the need for treatment after birth. However, no severe brain abnormalities were detected after birth in our cohort, and the only observed sequelae were sensorineural hearing loss.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Seidenari A, Dionisi C, Nati M, et al. Follow-Up of Infants With Congenital Cytomegalovirus Following Maternal Primary Infection in the First Trimester and Normal Fetal Brain Imaging at Midgestation. Prenat Diagn. 2024. PMID: 39694858. doi:10.1002/pd.6731

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。